Insider Trading: Repros Therapeutics Inc (RPRX.W)

RPRX.W on CBOE When Trading NASDAQ Global Select Market

16.50USD
24 May 2013
Price Change (% chg)

$0.72 (+4.56%)
Prev Close
$15.78
Open
$15.85
Day's High
$16.81
Day's Low
$15.85
Volume
1,500
Avg. Vol
4,248
52-wk High
$20.18
52-wk Low
$7.78

Search Stocks
PERCEPTIVE ADVISORS L L C Options Exercised: 0
Trade Date: Sunday, 7 Aug 2011 Price: 7.50
Title: Beneficial Owner of More than 10% Class Shares Held: 1,581,660
Type Traded: Indirect Net Change in Shares This Filing: 23,600

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 96
Total Shares Held: 18,818,676
3 Mo. Net Change: 5,705,074
# New Positions: 24
# Closed Positions: 13
# Increased Positions: 54
# Reduced Positions: 35
# Net Buyers: 19

Officers & Directors

Name Age Since Current Position

Nola Masterson

65 2009 Independent Chairman of the Board

Joseph Podolski

64 2009 President, Chief Executive Officer, Director

Katherine Anderson

54 2011 Chief Financial Officer, Chief Accounting Officer, Secretary

Jaye Thompson

47 2013 Senior Vice President - Clinical and Regulatory

Ronald Wiehle

63 Vice President - Research & Development

Saira Ramasastry

2013 Director

Daniel Cain

66 2008 Independent Director

Michael Wyllie

61 2011 Independent Director
Search Stocks